524632-BOM

Shukra Pharmaceuticals Ltd.

BSE: 524632

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

34.45-0.0 (-0.03%)

10 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

89.6 / 100

Value Score

5.9 / 100

Price Momentum Score

39.9 / 100

QVM Score

36.9 / 100

Key Metrics

Market Cap

1514.47

P/E (TTM)

68.66

P/B

16.86

P/S (TTM)

26.70

EV/EBITDA

52.67

CAPE (5Y)

94.53

ROE (TTM)

28.89

ROCE (TTM)

31.25

ROA (TTM)

21.60

Avg 3Y ROE

29.83

Earnings 3Y CAGR

-8.62

Sales 3Y CAGR

-1.21

Sales 5Y CAGR

38.34

Debt/Equity

0.06

Consensus TP

Strong Buy %

Promoter Holding

50.96

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Shukra Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

High and improving ROE

The company reported strong ROE of 28.89% for 12-month ended 31 Mar 2026 and ROE improved by 1298 bps from 1 year ago

What is ROE (FY)?

High and improving operating margin

The company reported strong operating margin of 44.59% for 12-month ended 31 Mar 2026 and operating margin improved by 1475 bps from 1 year ago

What is Operating profit margin?

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 74.08% for 12-month ended 31 Mar 2026 and the growth was 62.84 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 11.24

Value 74.08

-82.35114662

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 128.62% for 12-month ended 31 Mar 2026 and the growth was 120.5 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.06 as on 31 Mar 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 4 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 68.66 indicates that the stock is expensive on a standalone basis and is at a 121.27% premium to industry median P/E

What is P/E Ratio?

Median: 31.03

Value 68.66

-215.443203.67

Low dividend yield

The company has a low dividend yield of 0.03%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 32.8 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

32.8 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Shukra Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Shukra Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Shukra Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	49.17	49.17	49.17	49.17	49.17	49.17	49.17	49.17	49.17	49.17	49.17	49.17	50.90	50.90	50.90	50.96	50.96	50.96	50.96	50.96	50.96	50.96	50.96	50.96	50.96
Indian Promoter	49.17	49.17	49.17	49.17	49.17	49.17	49.17	49.17	49.17	49.17	49.17	49.17	50.90	50.90	50.90	50.96	50.96	50.96	50.96	50.96	50.96	50.96	50.96	50.96	50.96
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11	0.11
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	50.04	50.04	50.04	50.04	50.04	50.04	50.04	50.04	50.04	50.04	50.04	50.04	48.99	48.99	48.99	48.93	48.93	48.93	48.93	48.93	48.93	48.93	48.93	48.93	48.93
Bodies Corporate	0.22	0.22	0.20	0.20	0.19	0.19	0.19	0.18	0.42	0.41	0.28	0.23	0.30	0.12	0.11	0.13	0.25	0.38	0.27	0.06	0.14	0.11	0.11	0.10	0.14
Others (incl. Retail) No. of shareholders	49.82 9,415	49.82 9,429	49.84 9,410	49.84 9,372	49.85 9,309	49.85 9,309	49.85 9,269	49.86 9,233	49.62 9,203	49.63 9,162	49.76 9,204	49.81 9,203	48.69 9,498	48.87 9,548	48.88 9,715	48.80 10,929	48.68 12,932	48.55 14,943	48.66 16,278	48.87 17,800	48.79 18,190	48.82 20,296	48.82 21,400	48.83 25,607	48.79 27,127

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Shukra Pharmaceuticals Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

Corporate Actions

History of Shukra Pharmaceuticals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.01/share
Record date: 18th Sep 2025Ex-date: 18th Sep 2025
Announced on: 4th Jun 2025
Stock Split1 : 10
Ex-date: 21st Mar 2025Announced on: 7th Mar 2025
Nominal Value changes from INR 10 to INR 1.
Dividend₹ 1/share
Record date: 24th Sep 2024Ex-date: 23rd Sep 2024
Announced on: 29th May 2024
Bonus3 new shares for 1 existing shares
Ex-date: 19th Apr 2024Announced on: 29th Feb 2024
Dividend₹ 0.50/share
Record date: 15th Sep 2023Ex-date: 15th Sep 2023
Announced on: 29th May 2023

Company Profile

Overview of Shukra Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Shukra Pharmaceuticals Limited is an India-based pharmaceutical company engaged in developing, manufacturing and marketing a range of pharmaceutical products globally and domestically. The Company’s product portfolio consists of tablet and capsules (general) solid oral dosage form and small volume p...

Incorporated on

04 Mar 1993

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

18 Jul 1994

Free Float

4,84,78,840

Website

http://www.shukrapharmaceuticals.com/

Phone no.

+912764286317

Address

Veer House, 3rd Floor, Judges Bungalow Road, Opp. WIAA Motor Training School, Bodakdev, AHMEDABAD, 380054, India

Frequently Asked Questions

What is the current share price of Shukra Pharmaceuticals Ltd.?

The current share price of Shukra Pharmaceuticals Ltd. is ₹ 34.45 as of 10 Jul 2026.

What is the market capitalisation of Shukra Pharmaceuticals Ltd.?

The market capitalisation of Shukra Pharmaceuticals Ltd. stands at ₹ 1,514.47 Cr.

What is the PE ratio of Shukra Pharmaceuticals Ltd.?

The Price-to-Earnings (PE) ratio of Shukra Pharmaceuticals Ltd. is 68.66 as of the latest trailing twelve months data.

What is the ROE and ROCE of Shukra Pharmaceuticals Ltd.?

Shukra Pharmaceuticals Ltd. has a Return on Equity (ROE) of 28.89% and a Return on Capital Employed (ROCE) of 31.25% as per the latest financial reports.

What is the 52-week high and low of Shukra Pharmaceuticals Ltd.?

The 52-week high of Shukra Pharmaceuticals Ltd. is - and the 52-week low is -.

What is the dividend yield of Shukra Pharmaceuticals Ltd.?

The dividend yield of Shukra Pharmaceuticals Ltd. is 0.03% based on the current market price.

What is the FII and DII holding in Shukra Pharmaceuticals Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.11% and retail/public investors hold 48.79% of Shukra Pharmaceuticals Ltd. shares.

What sector does Shukra Pharmaceuticals Ltd. belong to?

Shukra Pharmaceuticals Ltd. operates in the Healthcare sector.

What is the beta of Shukra Pharmaceuticals Ltd.?

The beta of Shukra Pharmaceuticals Ltd. is 0.77, indicating its price volatility relative to the broader market. Over the past 1 year, Shukra Pharmaceuticals Ltd. has delivered an absolute return of 118.04%.

What is the RSI of Shukra Pharmaceuticals Ltd.?

The 14-day Relative Strength Index (RSI) of Shukra Pharmaceuticals Ltd. is 65.93, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Shukra Pharmaceuticals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Shukra Pharmaceuticals Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Corporate Actions